Objective: Observational studies have associated diabetes with a decreased risk of prostate cancer. We aimed to evaluate this association using the General Practitioner Research Database in the UK.
Methods: Population based case–control study nested in a cohort.
Results: We identified 2,183 incident cases of prostate cancer between January 1995 and December 2001. We found that diabetic patients had a decreased risk of prostate cancer (OR = 0.72; 95% CI: 0.59–0.87). This association was observed among treated diabetics (OR = 0.63; 95% CI: 0.50–0.80) but not among untreated diabetics (OR = 1.01; 95% CI: 0.73–1.40). Our results suggest that the observed reduced risk could be restricted to users of insulin or sulphonylureas.
Conclusion: Patients with diabetes have a decreased risk of prostate cancer. The role of antidiabetic treatment in this association warrants further research.
diabetes mellitus epidemiologic studies prostate cancer
Stattin, P, Rinaldi, S, Biessy, C, Stenman, UH, Hallmans, G, Kaaks, R 2004High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohortJ Clin Oncol2231043112CrossRefPubMedGoogle Scholar
Suikkari, AM, Koivisto, VA, Rutanen, EM, Yki-Jarvinen, H, Karonen, SL, Seppala, M 1988Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding proteinJ Clin Endocrinol Metab66266272PubMedGoogle Scholar
Orskov, H 1996Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes?Metabolism459195CrossRefPubMedGoogle Scholar
García Rodríguez, LA, Pérez Gutthann, S 1998Use of the U.K. General Practice Research Database for pharmacoepidemiologyBr J Clin Pharmacol45419426CrossRefPubMedGoogle Scholar
Jick, H, Jick, SS, Derby, LE 1991Validation of information recorded on general practitioner based computerised data resource in the United KingdomBMJ302766768PubMedGoogle Scholar
García Rodríguez, LA, González-Pérez, A 2004Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancerCancer Epidemiol Biomar Prev13649653Google Scholar
Ronquist, G, García Rodríguez, LA, Ruigómez, A, et al. 2004Association between captopril, other antihypertensive drugs and risk of prostate cancerProstate585056CrossRefPubMedGoogle Scholar
Zhu, K, Lee, IM, Sesso, HD, Buring, JE, Levine, RS, Gaziano, JM 2004History of diabetes mellitus and risk of prostate cancer in physiciansAm J Epidemiol159978982CrossRefPubMedGoogle Scholar
Coker, AL, Sanderson, M, Zheng, W, Fadden, MK 2004Diabetes mellitus and prostate cancer risk among older men: population-based case-control studyBr J Cancer90 21712175PubMedGoogle Scholar
Coughlin, SS, Calle, EE, Teras, LR, Petrelli, J, Thun, MJ 2004Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adultsAm J Epidemiol15911601167CrossRefPubMedGoogle Scholar
Joint Health Surveys Unit1999Health Survey for England 1998The Stationery OfficeLondonGoogle Scholar
Hippisley-Cox, J, Pringle, M 2004Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional surveyLancet364423428CrossRefPubMedGoogle Scholar
Rosenberg, DJ, Neugut, AI, Ahsan, H, Shea, S 2002Diabetes mellitus and the risk of prostate cancerCancer Invest20157165CrossRefPubMedGoogle Scholar
DeFronzo, RA 1999Pharmacologic therapy for type 2 diabetes mellitusAnn Intern Med131281303PubMedGoogle Scholar
Scheen, AJ, Lefebvre, PJ 1998Oral antidiabetic agents. A guide to selectionDrugs55225236PubMedGoogle Scholar